prehospital aortic occlusion device

sible source and no other supplies or services will satisfy agency requirements. The proposed source is MicroVention, Inc. (MicroVention), 35 Enterprise, Aliso Viejo, CA 92656-2601. NMRC has a requirement for completion of testing required for the submission of a 510(k) (Premarket Notification) for

a prehospital aortic occlusion device to the Food and Drug Administration (FDA). Completion of the testing is required for the subsequent submission of the 510(k) application to the FDA. Completion of the required testing must be inclusive